Three New FDA-Approved Diabetes Drugs May Cause Diabetic Comas

Three New FDA-Approved Diabetes Drugs May Cause Diabetic Comas

However, there are good natural approaches to managing or even curing some forms of diabetes. The FDA recently posted a warning that three drugs used to treat type 2 diabetes—canagliflozin (brand name: Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance)—may lead to diabetic ketoacidosis, or DKA. Ketoacidosis is a condition that can lead to diabetic coma and even death. […]

Read More
Just How Many Conventional Docs are in the Pocket of Big Pharma? The Evidence Is Disturbing

Just How Many Conventional Docs are in the Pocket of Big Pharma? The Evidence Is Disturbing

New government data show drug and medical device makers paid a shocking $6.49 billion to doctors and hospitals in 2014. It’s no secret that the pharmaceutical industry has an incestuous—and incredibly profitable—relationship with some of the doctors who prescribe their drugs to patients. But a new set of data compiled by the Centers for Medicare […]

Read More
More Dying Patients Being Denied Access to Dr. Burzynski’s Life-Saving Treatment

More Dying Patients Being Denied Access to Dr. Burzynski’s Life-Saving Treatment

The FDA is effectively signing the death warrant of more patients by denying them access to Dr. Burzynski’s antineoplaston cancer treatment—for no rational reason whatsoever. Please help. Action Alert! Over the years, we’ve covered the FDA’s attacks on Dr. Stanislaw Burzynski, the trailblazing cancer doctor best known for his discovery and development of antineoplastons (ANP), […]

Read More
FDA “Compounds” Its Attack on Supplements

FDA “Compounds” Its Attack on Supplements

The FDA’s hostility toward both supplements and compounded medicine is legendary—after all, they compete with the FDA-approved drugs that pay the government’s bills. Now the agency is attacking compounded supplements. Action Alert! A few weeks ago, we reported on an amendment designed to fix a number of the most problematic regulations arising from Congress’s Drug […]

Read More